News
4h
News-Medical.Net on MSNNasal antibody spray shields mice from pollen-triggered allergies and asthmaIntranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...
17h
The Brighterside of News on MSNOxytocin nasal spray shows promise for treating alcoholism and obesityOxytocin, often called the “love hormone” for its role in social bonding and maternal behaviors, is now being investigated for something unexpected—its ability to regulate addictive behaviors and ...
THE POLLEN count is set to soar this week, leaving many with itchy, red eyes and a runny nose. Hayfever affects almost 10 ...
HRG reviewed 27 products in the health category, 125 items in the wellness sector and 53 products in the beauty aisle to see ...
US FDA accepts for review Milestone Pharma’s response to CRL for Cardamyst nasal spray: Montreal Monday, July 14, 2025, 11:00 Hrs [IST] Milestone Pharmaceuticals Inc., a biophar ...
A man from Windham was arrested after an arrest warrant that stemmed from an investigation in June, where Troopers responded to the parking lot of a restaurant on Boston Turnpike in Bolton following ...
My nose runs at the slightest thing - I suffer from hayfever even during the winter, but my nose runs worse when I eat. It's ...
21h
Doncaster Free Press on MSNLife-saving nasal spray Naloxone administered to two people suffering drug overdoses in Sheffield and DoncasterTwo sergeants have administered the life-saving nasal spray Naloxone to two people suffering from a drug overdose in Sheffield and Doncaster.
A pharmaceutical company is closing its Wilmington manufacturing facility this year and plans to lay off 75 people who work ...
More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia ...
Calling upon all relevant stakeholders to position local pharmaceutical manufacturing as a ‘thrust industry’ which can reduce ...
Acute Repetitive Seizures Market Analysis: Trends, Opportunities & North America Outlook (2025–2035)
Overview of Acute Repetitive Seizures MarketThe global Acute Repetitive Seizures Market is valued at USD 3.2 Billion in 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results